Ionis Pharmaceuticals, Inc. (IONS)
NASDAQ: IONS · Real-Time Price · USD
75.27
+0.51 (0.68%)
At close: May 1, 2026, 4:00 PM EDT
75.30
+0.03 (0.04%)
After-hours: May 1, 2026, 7:45 PM EDT

Ionis Pharmaceuticals Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
May '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
12,44112,9195,5207,3025,3664,297
Market Cap Growth
176.05%134.02%-24.40%36.09%24.87%-45.86%
Enterprise Value
13,07411,8514,6306,3714,7403,430
Last Close Price
75.2779.1134.9650.5937.7730.43
PE Ratio
--33.24-11.50-19.76-19.88-152.15
PS Ratio
11.7613.697.839.279.135.30
PB Ratio
25.4126.419.3818.899.375.57
P/TBV Ratio
25.6225.888.8818.749.355.56
P/FCF Ratio
--40.37-10.11-22.04-18.50228.03
P/OCF Ratio
--48.10-11.02-23.75-19.56139.52
EV/Sales Ratio
12.3512.566.578.098.074.23
EV/EBITDA Ratio
--33.01-10.22-19.24-12.21-322.75
EV/EBIT Ratio
--31.05-9.75-18.01-11.56-113.61
EV/FCF Ratio
--37.03-8.48-19.23-16.34182.00
Debt / Equity Ratio
3.273.292.393.622.381.62
Debt / EBITDA Ratio
-6.23-5.69-3.11-4.36-3.51-117.40
Debt / FCF Ratio
-2.10-6.38-2.58-4.36-4.6966.20
Net Debt / Equity Ratio
0.25-1.30-1.51-2.29-1.09-1.12
Net Debt / EBITDA Ratio
-0.371.771.972.681.6181.64
Net Debt / FCF Ratio
-0.121.991.632.682.15-46.03
Asset Turnover
0.300.290.240.290.230.32
Inventory Turnover
2.231.411.120.620.600.46
Quick Ratio
2.783.517.735.426.469.05
Current Ratio
4.103.838.475.907.079.75
Return on Equity (ROE)
-66.70%-70.80%-93.10%-76.34%-40.12%-3.78%
Return on Assets (ROA)
-10.16%-11.75%-15.64%-14.05%-16.67%-1.18%
Return on Invested Capital (ROIC)
-36.56%-70.95%-103.90%-102.50%-123.01%-8.69%
Return on Capital Employed (ROCE)
-12.87%-14.04%-18.15%-14.85%-17.86%-1.45%
Earnings Yield
-2.63%-3.01%-8.70%-5.06%-5.03%-0.66%
FCF Yield
-7.81%-2.48%-9.89%-4.54%-5.41%0.44%
Buyback Yield / Dilution
-5.71%-7.02%-4.42%-0.95%-0.59%-1.01%
Total Shareholder Return
-5.71%-7.02%-4.42%-0.95%-0.59%-1.01%
Updated Apr 29, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q